Investigating Health Impacts of Exposure to Harmful Algal Blooms
Launched by ROSKAMP INSTITUTE INC. · Mar 12, 2025
Trial Information
Current as of April 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating the health effects of harmful algal blooms, particularly focusing on a toxin called brevetoxin that is released during red tide events in Florida. The study aims to understand how exposure to these toxins might be linked to neurological disorders, which affect the brain and nervous system. Researchers are looking for adult participants who live in certain counties in southwest Florida, are at least 18 years old, and can provide consent to join the study.
If you decide to participate, you’ll need to attend at least four study visits and provide some biological samples during the trial. The study is open to people of all races and ethnicities, but you must be able to speak and write in English. If you have any medical conditions that might make it unsafe for you to join, or if you have difficulty giving blood samples, you may not be eligible. This research is important as it could help us better understand the health impacts of these environmental toxins on our communities.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Subject should be able to provide written informed consent.
- • 2. Adult aged 18 or older.
- • 3. Resident (temporary or permanent) of one of the following five southwest Florida counties (Lee, Collier, Charlotte, Sarasota, or Manatee).
- • 4. Any race or ethnicity.
- • 5. Willing to return for at least a total of four study visits and participate in all required procedures for the duration of the study.
- Exclusion Criteria:
- • 1. Inability to speak or write in English.
- • 2. Any medical condition for which the study investigator believes enrollment is medically inappropriate.
- • 3. Unwilling/unable to provide biological samples or poor venous access.
Trial Officials
Laila Abdullah Principal Investigator, Ph.D
Principal Investigator
The Roskamp Institute
About Roskamp Institute Inc.
Roskamp Institute Inc. is a leading nonprofit research organization dedicated to advancing the understanding and treatment of neurocognitive disorders, primarily focusing on Alzheimer's disease and related conditions. With a commitment to innovative research and clinical trials, the Institute collaborates with esteemed academic institutions and industry partners to develop novel therapeutic approaches. Its multidisciplinary team of experts combines clinical expertise with cutting-edge scientific methodologies, striving to translate research findings into effective interventions that improve patient outcomes and enhance quality of life. Through its rigorous approach to clinical investigation, Roskamp Institute Inc. aims to contribute significantly to the field of neurodegenerative disease research and treatment.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sarasota, Florida, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported